These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 10394556)
1. Uterine rupture after use of a prostaglandin E2 vaginal insert during vaginal birth after cesarean. A report of two cases. Raskin KS; Dachauer JD; Doeden AL; Rayburn WF J Reprod Med; 1999 Jun; 44(6):571-4. PubMed ID: 10394556 [TBL] [Abstract][Full Text] [Related]
2. Uterine rupture with the use of PGE2 vaginal inserts for labor induction in women with previous cesarean sections. Taylor DR; Doughty AS; Kaufman H; Yang L; Iannucci TA J Reprod Med; 2002 Jul; 47(7):549-54. PubMed ID: 12170531 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 for cervical ripening: a multicenter study of patients with prior cesarean delivery. Flamm BL; Anton D; Goings JR; Newman J Am J Perinatol; 1997 Mar; 14(3):157-60. PubMed ID: 9259919 [TBL] [Abstract][Full Text] [Related]
4. Vaginal birth after cesarean section: risk of uterine rupture with labor induction. Ouzounian JG; Miller DA; Hiebert CJ; Battista LR; Lee RH Am J Perinatol; 2011 Sep; 28(8):593-6. PubMed ID: 21424988 [TBL] [Abstract][Full Text] [Related]
5. Posterior uterine rupture in a woman with a previous Cesarean delivery. Figueroa R; Garry D; Mackenzie AP J Matern Fetal Neonatal Med; 2003 Aug; 14(2):130-1. PubMed ID: 14629095 [TBL] [Abstract][Full Text] [Related]
6. Obstetric outcomes after cervical ripening by multiple doses of vaginal prostaglandin E2. Chan LY; Fu L; Leung TN; Wong SF; Lau TK Acta Obstet Gynecol Scand; 2004 Jan; 83(1):70-4. PubMed ID: 14678088 [TBL] [Abstract][Full Text] [Related]
7. Induction of labor with prostaglandin E2 in women with previous cesarean section and unfavorable cervix. Yogev Y; Ben-Haroush A; Lahav E; Horowitz E; Hod M; Kaplan B Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):173-6. PubMed ID: 15358459 [TBL] [Abstract][Full Text] [Related]
8. Cervical ripening by prostaglandin E2 in patients with a previous cesarean section. Bouchghoul H; Zeino S; Houllier M; Senat MV J Gynecol Obstet Hum Reprod; 2020 Apr; 49(4):101699. PubMed ID: 32018044 [TBL] [Abstract][Full Text] [Related]
9. Trial of labor and vaginal birth after cesarean section in patients with uterine Müllerian anomalies: a population-based study. Erez O; Dukler D; Novack L; Rozen A; Zolotnik L; Bashiri A; Koifman A; Mazor M Am J Obstet Gynecol; 2007 Jun; 196(6):537.e1-11. PubMed ID: 17547885 [TBL] [Abstract][Full Text] [Related]
10. Rupture of the scarred uterus. Grossetti E; Vardon D; Creveuil C; Herlicoviez M; Dreyfus M Acta Obstet Gynecol Scand; 2007; 86(5):572-8. PubMed ID: 17464586 [TBL] [Abstract][Full Text] [Related]
11. Risk of uterine rupture with a trial of labor in women with multiple and single prior cesarean delivery. Landon MB; Spong CY; Thom E; Hauth JC; Bloom SL; Varner MW; Moawad AH; Caritis SN; Harper M; Wapner RJ; Sorokin Y; Miodovnik M; Carpenter M; Peaceman AM; O'sullivan MJ; Sibai BM; Langer O; Thorp JM; Ramin SM; Mercer BM; Gabbe SG; Obstet Gynecol; 2006 Jul; 108(1):12-20. PubMed ID: 16816050 [TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial. Ozkan S; Calişkan E; Doğer E; Yücesoy I; Ozeren S; Vural B Arch Gynecol Obstet; 2009 Jul; 280(1):19-24. PubMed ID: 19034471 [TBL] [Abstract][Full Text] [Related]
13. Abruptio placentae associated with misoprostol use in women with preeclampsia. Fontenot MT; Lewis DF; Barton CB; Jones EM; Moore JA; Evans AT J Reprod Med; 2005 Sep; 50(9):653-8. PubMed ID: 16363752 [TBL] [Abstract][Full Text] [Related]
14. A randomized trial of vaginal prostaglandin E2 for induction of labor. Insert vs. tablet. Rabl M; Joura EA; Yücel Y; Egarter C J Reprod Med; 2002 Feb; 47(2):115-9. PubMed ID: 11883349 [TBL] [Abstract][Full Text] [Related]
15. Uterine rupture and dehiscence associated with intravaginal misoprostol cervical ripening. Hill DA; Chez RA; Quinlan J; Fuentes A; LaCombe J J Reprod Med; 2000 Oct; 45(10):823-6. PubMed ID: 11077631 [TBL] [Abstract][Full Text] [Related]
16. Inducing labor with a sustained-release PGE2 vaginal insert. Experience at a community hospital. Blair FC; Tassone SA; Pearman CR; St Cyr MB; Rayburn WF J Reprod Med; 1998 May; 43(5):408-12. PubMed ID: 9610462 [TBL] [Abstract][Full Text] [Related]
17. [Uterine rupture without predisposing factors after a single vaginal PgE2 administration in prolonged pregnancy]. Zieger W; Leveringhaus A; Wischnik A; Melchert F Zentralbl Gynakol; 1995; 117(1):51-3. PubMed ID: 7879464 [TBL] [Abstract][Full Text] [Related]
18. Safety of low-dose prostaglandin E2 induction in grandmultiparous women with previous cesarean delivery. Haas J; Barzilay E; Chayen B; Lebovitz O; Yinon Y; Mazaki-Tovi S; Harel L J Matern Fetal Neonatal Med; 2014 Mar; 27(5):445-8. PubMed ID: 23841832 [TBL] [Abstract][Full Text] [Related]
19. SOGC clinical practice guidelines. Guidelines for vaginal birth after previous caesarean birth. Number 155 (Replaces guideline Number 147), February 2005. Society of Obstetricians and Gynaecologists of Canada Int J Gynaecol Obstet; 2005 Jun; 89(3):319-31. PubMed ID: 16001462 [TBL] [Abstract][Full Text] [Related]
20. Mode of delivery in pregnancies with premature rupture of membranes at or before term following induction of labor with vaginal prostaglandin E2. Ben-Haroush A; Yogev Y; Glickman H; Bar J; Kaplan B; Hod M Am J Perinatol; 2004 Jul; 21(5):263-8. PubMed ID: 15232758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]